Skip to main content
Premium Trial:

Request an Annual Quote

Zerhouni Confirms Kington to Take Over as NIH Acting Director

NEW YORK (GenomeWeb News) – Raynard Kington will step into the role of acting director of the National Institutes of Health on Friday, Oct. 31, after the departure of Elias Zerhouni, who announced in September that he plans to leave his post.
 
Zerhouni confirmed this week that he has tapped Kington to take over the post until a new director is appointed, which will happen sometime after the next administration settles into the White House.
 
Kington has served as Zerhouni’s deputy since 2003, and before that he was associate director of NIH for behavioral and social sciences research. He has also served as acting director of the National Institute on Alcohol Abuse and Alcoholism, and he worked at the National Center for Health Statistics.
 
Before his arrival at NIH, Kington was a senior scientist at the Rand Corporation, where he was co-director of the Drew/RAND Center on Health and Aging.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.